SCHEMBL11240455

SCHEMBL11240455

CCCCN(C(=O)CC(=O)OCC)c1ccc([Ge]OOO)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.40
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
PAX8 Q06710 2/20 0.37
JAK2 O60674 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MLYCD O95822 3/20 0.36
ALDH1A1 P00352 6/20 0.34
TP53 P04637 3/20 0.34
HDAC6 Q9UBN7 2/20 0.34
MAPT P10636 2/20 0.34
GPX4 P36969 1/20 0.34
ADRB2 P07550 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11236072 0.88 HTT (0.39) SMN1; SMN2MEN1KMT2AGAAALDH1A1
Water SCHEMBL11240458 0.79 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9APAX8JAK2
Water SCHEMBL11240451 0.79 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9APAX8JAK2
SCHEMBL11227688 0.77 SMN1; SMN2 (0.52) SMN1; SMN2GAACYP1A2CYP3A4CYP2C9
SCHEMBL11235371 0.75 ALDH1A1 (0.47) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL11230871 0.73 CYP4F2 (0.39) SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4
SCHEMBL11229519 0.73 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4
SCHEMBL6074707 0.71 ADRB2 (0.41) SMN1; SMN2NPC1RAB9APAX8JAK2
SCHEMBL11229858 0.68 SMN1; SMN2 (0.33) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL31318741 0.68 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4361579-A TREATMENT OF IMMUNE DISEASES WITH ORGANOGERMANIUM POLYMERS YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1982-11-30 US disclosed
EP-0025965-A2 Organogermanium compounds, a method for producing them and pharmaceutical compositions comprising them Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1981-04-01 EP disclosed